SlideShare una empresa de Scribd logo
1 de 23
CHF in the ED
Bryce C Inman, MD
Loma Linda University Medical Center
Congestive Heart Failure
• Congestive heart failure is an imbalance in
pump function in which the heart is unable to
maintain adequate forward blood flow.
• 10% of those > 80 years old
• Most common cause of death is progressive
heart failure
CHF: 2 types
Systolic
• EF < 40%
• Impaired ventricular
contraction
• Most commonly from
ischemic heart disease
Diastolic
• EF > 60%
• Impaired ventricular
relaxation
• Most commonly from
chronic HTN and LVH
Prognosis
• Heart failure has an overall poor prognosis
• Symptoms predict outcome
– 5-10% mortality per year in moderate CHF
– 30-40% mortality per year in severe CHF
Diagnosis: History
• Dyspnea at rest
• Dyspnea upon exertion
• Orthopnea
• Cough: Frothy pink sputum highly predictive
of CHF
• Nonspecifics: weakness, dizziness, malaise,
etc.
Diagnosis: Exam
• Acute pulmonary edema: Severe respiratory
distress , relative hypertension, diaphoretic
skin. Bilateral crackles can typically be heard
• An S3 has 99 percent specificity for an
elevated capillary wedge pressure (but 20%
sensitivity)
• JVD has 94 percent specificity for elevated
capillary wedge pressure (but 39% sensitivity)
Imaging
• 1/5 CHF patients admitted to the hospital
lacked signs on CXR
• Congestive signs on CXR are unreliable in
chronic CHF
• Sensitivity for CHF with a portable CXR is poor.
• CXR findings often lag behind clinical
manifestions by several hours
However, a CXR is useful to exclude other
processes (e.g., pneumothorax)
Pleural effusion
Pulmonary Edema
What about labs and EKG?
• Lack sensitivity and specificity
– Occasionally you might see an elevated AST/ALT
or prerenal azotemia
– EKG may show ischemia or previous MI,
dysrhythmias, etc.
Natriuretic peptides
• 70 y/o M presents with respiratory distress.
His 02 saturations are in the 70’s, he has mild
retractions, and breath sounds are difficult to
auscultate.
– Is this CHF or COPD?
• A BNP of <100 almost entirely excludes CHF
What else looks like acute CHF?
TREAT!
70 y/o M presents with respiratory distress. His 02
saturations are in the 70’s, he has mild retractions,
and breath sounds are difficult to auscultate.
Airway Management
• Airway management supercedes all other priorities in
these patients, particularly those who are critically ill.
• Hypoxia is a greater risk than hypercarbia so CO2
retention is not an immediate concern
o What is the best way to manage the airway?
Intubation vs NIPPV
Intubation
• Typically for those in severe
distress or those who are
non-cooperative.
BiPAP/CPAP
• May decrease the need for
intubations, but no
significant change in
mortality
Pressure Control
• Systolic pressure acceptable?
– Start nitroglycerin (0.4 mg PO q2-3 min)
– Nitrospray: Single spray (0.4 mg) up to a max of 1.2 mg
Ointment: Apply 1-2 inches of nitropaste to chest wall
IV: Start at 20 mcg/min IV and rate to effect in 5-10 mcg
increments q3-5min
• The failing heart is sensitive to increases in afterload;
these measures alleviate the pulmonary edema from
CHF.
Don’t venodilate when….
• Preload dependent states exist such as;
– Right ventricular infarct
– Critical aortic stenosis
– Volume depletion
Most require only oxygen, blood
pressure control, and diuresis
-Vasoconstricted patients require vasodilators.
-Congested patients required diuretics
★Diastolic HF patients respond better to BP
management than diuresis
Diuresis
• First line therapy is a diuretic such as furosemide.
– 10-20 mg IV for symptomatic CHF and diuretic naïve.
40-80 mg IV for patients already using diuretics
80-120 mg IV for patients whose symptoms are
refractory to the initial dose after 1 h of its
administration
• Metolazone, a thiazide diuretic, can be added for
effect.
If hypotensive…
• Inotropes including dobutamine and
dopamine are used primarily
– Dopamine starts at 5 mcg/kg/min IV and increase
at 5 mcg/kg/min increments to a 20 mcg/kg/min
dose
– Dobutamine starts at 2.5 mcg/kg/min IV; generally
therapeutic in the range of 10-40 mcg/kg/min
Admit or go home?
• With few exceptions, most patients
presenting with symptoms of CHF require
admission. Those who respond well to initial
interventions may require only basic ward
admission with telemetry.
• Those who had a gradual onset dyspnea, rapid
response to therapy, good oxygen saturations,
and ACS/MI unlikely as the inciting event may
be stable for discharge
In conclusion
• Airway management is goal
– IF NIPPV easily available, begin immediately and
monitor for progress or decline
• Control Pressure
– Use nitroglycerin and titrate to effect
– If known diastolic CHF, attempt to reduce
afterload
• Pressor support if hypotensive
– Dobutamine/dopamine

Más contenido relacionado

La actualidad más candente

Management of acute lvf
Management of acute lvfManagement of acute lvf
Management of acute lvfGautam Chakma
 
Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy)
Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy) Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy)
Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy) Abdullah Bilal
 
Pharmacotherapy of cardiac arrhythmias
Pharmacotherapy of cardiac arrhythmiasPharmacotherapy of cardiac arrhythmias
Pharmacotherapy of cardiac arrhythmiasVikas Sharma
 
Cardiac arrhythmias
Cardiac arrhythmiasCardiac arrhythmias
Cardiac arrhythmiasdratin75
 
Acute decompensated heart failure
Acute decompensated heart failure Acute decompensated heart failure
Acute decompensated heart failure ikramdr01
 
Acute decompensated heart failure
Acute decompensated heart failureAcute decompensated heart failure
Acute decompensated heart failureAreej Abu Hanieh
 
Sick sinus syndrome
Sick sinus syndromeSick sinus syndrome
Sick sinus syndromeelsayed41
 
Sinus and atrial arrhythmias
Sinus and atrial arrhythmiasSinus and atrial arrhythmias
Sinus and atrial arrhythmiasfarranajwa
 
Antiarrythmia
AntiarrythmiaAntiarrythmia
AntiarrythmiaStacy A.J
 
Bradycardias and conduction defects
Bradycardias and conduction defectsBradycardias and conduction defects
Bradycardias and conduction defectsAayushPokharel10
 
heart block presentation (1)
 heart block presentation  (1) heart block presentation  (1)
heart block presentation (1)ravijangid39
 
Rhythms of the Heart
Rhythms of the HeartRhythms of the Heart
Rhythms of the HeartEneutron
 
Cardiac Arrhtymia
Cardiac ArrhtymiaCardiac Arrhtymia
Cardiac ArrhtymiaHenry Eze
 
Pharmacotherapy of Cardiac arrhythmias
Pharmacotherapy of Cardiac arrhythmiasPharmacotherapy of Cardiac arrhythmias
Pharmacotherapy of Cardiac arrhythmiasDrSnehaDange
 

La actualidad más candente (20)

Clinical signs of arrythmia
Clinical signs of arrythmiaClinical signs of arrythmia
Clinical signs of arrythmia
 
Bradyarryhthmias
BradyarryhthmiasBradyarryhthmias
Bradyarryhthmias
 
Arrythmia
ArrythmiaArrythmia
Arrythmia
 
Management of acute lvf
Management of acute lvfManagement of acute lvf
Management of acute lvf
 
Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy)
Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy) Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy)
Arrhythmia - Pathophysiology and Treatment (Pharmacotherapy)
 
Cardiac dyrrythmias
Cardiac dyrrythmiasCardiac dyrrythmias
Cardiac dyrrythmias
 
Pharmacotherapy of cardiac arrhythmias
Pharmacotherapy of cardiac arrhythmiasPharmacotherapy of cardiac arrhythmias
Pharmacotherapy of cardiac arrhythmias
 
Cardiac arrhythmias
Cardiac arrhythmiasCardiac arrhythmias
Cardiac arrhythmias
 
Acute decompensated heart failure
Acute decompensated heart failure Acute decompensated heart failure
Acute decompensated heart failure
 
Acute decompensated heart failure
Acute decompensated heart failureAcute decompensated heart failure
Acute decompensated heart failure
 
Sick sinus syndrome
Sick sinus syndromeSick sinus syndrome
Sick sinus syndrome
 
Sinus and atrial arrhythmias
Sinus and atrial arrhythmiasSinus and atrial arrhythmias
Sinus and atrial arrhythmias
 
Antiarrythmia
AntiarrythmiaAntiarrythmia
Antiarrythmia
 
Bradycardias and conduction defects
Bradycardias and conduction defectsBradycardias and conduction defects
Bradycardias and conduction defects
 
heart block presentation (1)
 heart block presentation  (1) heart block presentation  (1)
heart block presentation (1)
 
Rhythms of the Heart
Rhythms of the HeartRhythms of the Heart
Rhythms of the Heart
 
Cardiac Arrhtymia
Cardiac ArrhtymiaCardiac Arrhtymia
Cardiac Arrhtymia
 
Arrthymias management
Arrthymias managementArrthymias management
Arrthymias management
 
ORTHOSTATIC HYPOTENSION
ORTHOSTATIC HYPOTENSIONORTHOSTATIC HYPOTENSION
ORTHOSTATIC HYPOTENSION
 
Pharmacotherapy of Cardiac arrhythmias
Pharmacotherapy of Cardiac arrhythmiasPharmacotherapy of Cardiac arrhythmias
Pharmacotherapy of Cardiac arrhythmias
 

Destacado

Destacado (20)

Congestive Heart Failure
Congestive Heart FailureCongestive Heart Failure
Congestive Heart Failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Pathophysiology of congestive heart failure
Pathophysiology of congestive heart failurePathophysiology of congestive heart failure
Pathophysiology of congestive heart failure
 
congestive heart failure
congestive heart failurecongestive heart failure
congestive heart failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Ccf
CcfCcf
Ccf
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Heart failure 2013 Pathophysiology
Heart failure 2013 PathophysiologyHeart failure 2013 Pathophysiology
Heart failure 2013 Pathophysiology
 
Chf
ChfChf
Chf
 
Pathophysiology hf.
Pathophysiology hf.Pathophysiology hf.
Pathophysiology hf.
 
Ccf
CcfCcf
Ccf
 
Heart Failure
Heart FailureHeart Failure
Heart Failure
 
CONGESTIVE CARDIAC FAILURE
CONGESTIVE CARDIAC FAILURECONGESTIVE CARDIAC FAILURE
CONGESTIVE CARDIAC FAILURE
 
Congestive Cardiac Failure
Congestive Cardiac FailureCongestive Cardiac Failure
Congestive Cardiac Failure
 
Acute Cholecystitis DR DILIP S.RAJPAL
Acute Cholecystitis DR DILIP S.RAJPALAcute Cholecystitis DR DILIP S.RAJPAL
Acute Cholecystitis DR DILIP S.RAJPAL
 
Congestive hf lect
Congestive hf lectCongestive hf lect
Congestive hf lect
 
Chronic cholecystitis
Chronic cholecystitisChronic cholecystitis
Chronic cholecystitis
 
A brief synopsis of acute decompensated heart failure
A brief synopsis of acute decompensated heart failureA brief synopsis of acute decompensated heart failure
A brief synopsis of acute decompensated heart failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Acute cholecystitis
Acute cholecystitisAcute cholecystitis
Acute cholecystitis
 

Similar a TUT CHF

Acute heart failure_ Murad Amro_ 20.pptx
Acute heart failure_ Murad Amro_ 20.pptxAcute heart failure_ Murad Amro_ 20.pptx
Acute heart failure_ Murad Amro_ 20.pptxmuradamro41
 
hypertension crisis junior hpt crisis pptx
hypertension crisis junior hpt crisis pptxhypertension crisis junior hpt crisis pptx
hypertension crisis junior hpt crisis pptxcmarosdi
 
Hypertension by Harrison Mbohe
Hypertension by Harrison MboheHypertension by Harrison Mbohe
Hypertension by Harrison MboheHarrisonMbohe
 
Management of cyanotic congenital heart diseae3
Management of  cyanotic congenital heart diseae3Management of  cyanotic congenital heart diseae3
Management of cyanotic congenital heart diseae3Sandip Gupta
 
Chronic Heart Failure- Pharmacotherapy
Chronic Heart Failure-  PharmacotherapyChronic Heart Failure-  Pharmacotherapy
Chronic Heart Failure- PharmacotherapyAreej Abu Hanieh
 
Cardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concernCardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concernUmang Sharma
 
atrial fibrillation, trupthi.pptx
atrial fibrillation, trupthi.pptxatrial fibrillation, trupthi.pptx
atrial fibrillation, trupthi.pptxTrupthiKM
 
cardiology-presentation4703-160125091644.pptx
cardiology-presentation4703-160125091644.pptxcardiology-presentation4703-160125091644.pptx
cardiology-presentation4703-160125091644.pptxkarthikeyan104187
 
Arrhythmia Diagnosis and Management.ppt
Arrhythmia Diagnosis and Management.pptArrhythmia Diagnosis and Management.ppt
Arrhythmia Diagnosis and Management.pptSesinuModupe
 
2.1. Heart Failure.ppt
2.1. Heart  Failure.ppt2.1. Heart  Failure.ppt
2.1. Heart Failure.pptAmareDejene
 
Acute Coronary Syndrome By Essam Sidqi
Acute Coronary Syndrome By Essam SidqiAcute Coronary Syndrome By Essam Sidqi
Acute Coronary Syndrome By Essam SidqiEssam Sidqi Yaqoob
 

Similar a TUT CHF (20)

Acute heart failure_ Murad Amro_ 20.pptx
Acute heart failure_ Murad Amro_ 20.pptxAcute heart failure_ Murad Amro_ 20.pptx
Acute heart failure_ Murad Amro_ 20.pptx
 
Heart failure
Heart failureHeart failure
Heart failure
 
hypertension crisis junior hpt crisis pptx
hypertension crisis junior hpt crisis pptxhypertension crisis junior hpt crisis pptx
hypertension crisis junior hpt crisis pptx
 
Hypertension - Approach & Management
Hypertension - Approach & ManagementHypertension - Approach & Management
Hypertension - Approach & Management
 
Hypertension by Harrison Mbohe
Hypertension by Harrison MboheHypertension by Harrison Mbohe
Hypertension by Harrison Mbohe
 
Management of cyanotic congenital heart diseae3
Management of  cyanotic congenital heart diseae3Management of  cyanotic congenital heart diseae3
Management of cyanotic congenital heart diseae3
 
Acute cardiovascular disorders
Acute cardiovascular disordersAcute cardiovascular disorders
Acute cardiovascular disorders
 
Essential hypertension
Essential hypertensionEssential hypertension
Essential hypertension
 
Chronic Heart Failure- Pharmacotherapy
Chronic Heart Failure-  PharmacotherapyChronic Heart Failure-  Pharmacotherapy
Chronic Heart Failure- Pharmacotherapy
 
Cardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concernCardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concern
 
atrial fibrillation, trupthi.pptx
atrial fibrillation, trupthi.pptxatrial fibrillation, trupthi.pptx
atrial fibrillation, trupthi.pptx
 
HEART FAILURE.pptx
HEART FAILURE.pptxHEART FAILURE.pptx
HEART FAILURE.pptx
 
New ppta.pptx n
New ppta.pptx nNew ppta.pptx n
New ppta.pptx n
 
cardiology-presentation4703-160125091644.pptx
cardiology-presentation4703-160125091644.pptxcardiology-presentation4703-160125091644.pptx
cardiology-presentation4703-160125091644.pptx
 
Arrhythmia Diagnosis and Management.ppt
Arrhythmia Diagnosis and Management.pptArrhythmia Diagnosis and Management.ppt
Arrhythmia Diagnosis and Management.ppt
 
2.1. Heart Failure.ppt
2.1. Heart  Failure.ppt2.1. Heart  Failure.ppt
2.1. Heart Failure.ppt
 
Acute Coronary Syndrome By Essam Sidqi
Acute Coronary Syndrome By Essam SidqiAcute Coronary Syndrome By Essam Sidqi
Acute Coronary Syndrome By Essam Sidqi
 
Anti htn drugs
Anti htn drugsAnti htn drugs
Anti htn drugs
 
Copd Management
Copd ManagementCopd Management
Copd Management
 
Heart failure
Heart failureHeart failure
Heart failure
 

Último

Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 

Último (20)

Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 

TUT CHF

  • 1. CHF in the ED Bryce C Inman, MD Loma Linda University Medical Center
  • 2. Congestive Heart Failure • Congestive heart failure is an imbalance in pump function in which the heart is unable to maintain adequate forward blood flow. • 10% of those > 80 years old • Most common cause of death is progressive heart failure
  • 3. CHF: 2 types Systolic • EF < 40% • Impaired ventricular contraction • Most commonly from ischemic heart disease Diastolic • EF > 60% • Impaired ventricular relaxation • Most commonly from chronic HTN and LVH
  • 4.
  • 5. Prognosis • Heart failure has an overall poor prognosis • Symptoms predict outcome – 5-10% mortality per year in moderate CHF – 30-40% mortality per year in severe CHF
  • 6. Diagnosis: History • Dyspnea at rest • Dyspnea upon exertion • Orthopnea • Cough: Frothy pink sputum highly predictive of CHF • Nonspecifics: weakness, dizziness, malaise, etc.
  • 7. Diagnosis: Exam • Acute pulmonary edema: Severe respiratory distress , relative hypertension, diaphoretic skin. Bilateral crackles can typically be heard • An S3 has 99 percent specificity for an elevated capillary wedge pressure (but 20% sensitivity) • JVD has 94 percent specificity for elevated capillary wedge pressure (but 39% sensitivity)
  • 8. Imaging • 1/5 CHF patients admitted to the hospital lacked signs on CXR • Congestive signs on CXR are unreliable in chronic CHF • Sensitivity for CHF with a portable CXR is poor. • CXR findings often lag behind clinical manifestions by several hours However, a CXR is useful to exclude other processes (e.g., pneumothorax)
  • 11. What about labs and EKG? • Lack sensitivity and specificity – Occasionally you might see an elevated AST/ALT or prerenal azotemia – EKG may show ischemia or previous MI, dysrhythmias, etc.
  • 12. Natriuretic peptides • 70 y/o M presents with respiratory distress. His 02 saturations are in the 70’s, he has mild retractions, and breath sounds are difficult to auscultate. – Is this CHF or COPD? • A BNP of <100 almost entirely excludes CHF
  • 13. What else looks like acute CHF?
  • 14. TREAT! 70 y/o M presents with respiratory distress. His 02 saturations are in the 70’s, he has mild retractions, and breath sounds are difficult to auscultate.
  • 15. Airway Management • Airway management supercedes all other priorities in these patients, particularly those who are critically ill. • Hypoxia is a greater risk than hypercarbia so CO2 retention is not an immediate concern o What is the best way to manage the airway?
  • 16. Intubation vs NIPPV Intubation • Typically for those in severe distress or those who are non-cooperative. BiPAP/CPAP • May decrease the need for intubations, but no significant change in mortality
  • 17. Pressure Control • Systolic pressure acceptable? – Start nitroglycerin (0.4 mg PO q2-3 min) – Nitrospray: Single spray (0.4 mg) up to a max of 1.2 mg Ointment: Apply 1-2 inches of nitropaste to chest wall IV: Start at 20 mcg/min IV and rate to effect in 5-10 mcg increments q3-5min • The failing heart is sensitive to increases in afterload; these measures alleviate the pulmonary edema from CHF.
  • 18. Don’t venodilate when…. • Preload dependent states exist such as; – Right ventricular infarct – Critical aortic stenosis – Volume depletion
  • 19. Most require only oxygen, blood pressure control, and diuresis -Vasoconstricted patients require vasodilators. -Congested patients required diuretics ★Diastolic HF patients respond better to BP management than diuresis
  • 20. Diuresis • First line therapy is a diuretic such as furosemide. – 10-20 mg IV for symptomatic CHF and diuretic naïve. 40-80 mg IV for patients already using diuretics 80-120 mg IV for patients whose symptoms are refractory to the initial dose after 1 h of its administration • Metolazone, a thiazide diuretic, can be added for effect.
  • 21. If hypotensive… • Inotropes including dobutamine and dopamine are used primarily – Dopamine starts at 5 mcg/kg/min IV and increase at 5 mcg/kg/min increments to a 20 mcg/kg/min dose – Dobutamine starts at 2.5 mcg/kg/min IV; generally therapeutic in the range of 10-40 mcg/kg/min
  • 22. Admit or go home? • With few exceptions, most patients presenting with symptoms of CHF require admission. Those who respond well to initial interventions may require only basic ward admission with telemetry. • Those who had a gradual onset dyspnea, rapid response to therapy, good oxygen saturations, and ACS/MI unlikely as the inciting event may be stable for discharge
  • 23. In conclusion • Airway management is goal – IF NIPPV easily available, begin immediately and monitor for progress or decline • Control Pressure – Use nitroglycerin and titrate to effect – If known diastolic CHF, attempt to reduce afterload • Pressor support if hypotensive – Dobutamine/dopamine

Notas del editor

  1. RAAS and sympathetic nervous system activation lead to increased norepin, vasopression  sodium/water retention Cardiac remodeling
  2. Often missed on CXR, especially if patient is intubated and supine.
  3. High output state e.g. anemia or sepsis